© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

L'Oréal glams up with Sfr500m debut in Swiss francs

French company diversifies funding after inaugural dollar deal last year
Several banks are reining in their appetite for warehouse lending

On DLT, regulators could bring order — or disruption

Markets are looking to the authorities to simplify blockchain issues, but they may not have the purest motives

Elevated rates dampen appetite for long-dated corporate bonds

Issuance beyond 15 years could return if rates stabilise
Several banks are reining in their appetite for warehouse lending
Sub-sections
  • India’s Glenmark Life Sciences, a pharmaceutical ingredients maker, has filed draft paperwork for an IPO of new and existing shares.
  • Chinese company Zhaoke Ophthalmology has kicked off a Hong Kong IPO worth up to HK$2.1bn ($270m), becoming the latest biotechnology company to sell shares on the bourse.
  • More than 90% of Suriname’s bondholders this week participated in a consent solicitation that extends the sovereign’s debt standstill until the end of July. But the government has only until April 30 to sign a deal with the IMF, or the standstill will be cancelled.